Absolute levels of sCD14 (−130.83 ng/mL, P = .08, −8.63%, P = .27) and oxidized LDL (−4.29 U/mL, P = .126, −9.07%, P = .28) tended to decrease with semaglutide treatment but these changes did not reach statistical significance ( Table 3 ).
← all excerpts
The Effects of Semaglutide on Inflammation and Immune Activation in HIV-associated Lipohypertrophy.
1
—
—